JPWO2021101962A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021101962A5
JPWO2021101962A5 JP2022528946A JP2022528946A JPWO2021101962A5 JP WO2021101962 A5 JPWO2021101962 A5 JP WO2021101962A5 JP 2022528946 A JP2022528946 A JP 2022528946A JP 2022528946 A JP2022528946 A JP 2022528946A JP WO2021101962 A5 JPWO2021101962 A5 JP WO2021101962A5
Authority
JP
Japan
Prior art keywords
common
cells
peptide
neoepitopes
identified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022528946A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023522512A (ja
JP2023522512A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/061009 external-priority patent/WO2021101962A1/en
Publication of JP2023522512A publication Critical patent/JP2023522512A/ja
Publication of JPWO2021101962A5 publication Critical patent/JPWO2021101962A5/ja
Publication of JP2023522512A5 publication Critical patent/JP2023522512A5/ja
Pending legal-status Critical Current

Links

JP2022528946A 2019-11-18 2020-11-18 共通のネオエピトープワクチンのための改善された組成物及び方法 Pending JP2023522512A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962936654P 2019-11-18 2019-11-18
US62/936,654 2019-11-18
US202062959440P 2020-01-10 2020-01-10
US62/959,440 2020-01-10
US202062982173P 2020-02-27 2020-02-27
US62/982,173 2020-02-27
PCT/US2020/061009 WO2021101962A1 (en) 2019-11-18 2020-11-18 Improved compositions and methods for shared neo-epitope vaccines

Publications (3)

Publication Number Publication Date
JP2023522512A JP2023522512A (ja) 2023-05-31
JPWO2021101962A5 true JPWO2021101962A5 (https=) 2023-11-29
JP2023522512A5 JP2023522512A5 (https=) 2023-11-29

Family

ID=73835748

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022528946A Pending JP2023522512A (ja) 2019-11-18 2020-11-18 共通のネオエピトープワクチンのための改善された組成物及び方法

Country Status (5)

Country Link
US (2) US20210145951A1 (https=)
EP (1) EP4062177A1 (https=)
JP (1) JP2023522512A (https=)
CA (1) CA3158646A1 (https=)
WO (1) WO2021101962A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202144388A (zh) 2020-02-14 2021-12-01 美商健生生物科技公司 在卵巢癌中表現之新抗原及其用途
CN119462833A (zh) * 2023-11-21 2025-02-18 上海市第一人民医院 肿瘤抗原肽及其用途
US20250197924A1 (en) * 2023-12-15 2025-06-19 Amazon Technologies, Inc. Methods for selection and combination of sequencing results from biological samples for neoantigen scoring

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3323070B1 (en) * 2015-07-14 2024-05-08 Personal Genome Diagnostics Inc. Neoantigen analysis
WO2017147139A1 (en) * 2016-02-22 2017-08-31 Oceanside Biotechnology Neoantigen compositions and methods of using the same in immunooncotherapy
WO2019036043A2 (en) * 2017-08-16 2019-02-21 Medgenome Inc. METHOD FOR GENERATING A COCKTAIL OF PERSONALIZED ANTICANCER VACCINES FROM TUMOR DERIVED GENETIC MODIFICATIONS FOR THE TREATMENT OF CANCER
CN112368386A (zh) * 2018-05-23 2021-02-12 磨石肿瘤生物技术公司 共有抗原

Similar Documents

Publication Publication Date Title
JP7592060B2 (ja) 免疫原性変異体ペプチドスクリーニングプラットフォーム
US20120077696A1 (en) Soluble hla complexes for use in disease diagnosis
JP2005501547A (ja) 修飾された第ｉｘ因子
Tang et al. A lncRNA Dleu2-encoded peptide relieves autoimmunity by facilitating Smad3-mediated Treg induction
JP2004535173A (ja) 低減された免疫原性を有する修飾されたインターフェロンアルファ
EP4126013A2 (en) Tumor antigens for liver cancer immunotherapy
Welner et al. Identification and mapping of a linear epitope of centromere protein F using monoclonal antibodies
Chen et al. Evaluation of spike protein epitopes by assessing the dynamics of humoral immune responses in moderate COVID-19
KR20030082962A (ko) 감소된 면역원성을 갖는 개질된과립구대식세포집락자극인자(ｇｍ-ｃｓｆ)
JPWO2021101962A5 (https=)
JP2005501546A (ja) 修飾されたヒト成長ホルモン
JP2025531430A (ja) 代替的翻訳制御に由来する１つまたはいくつかの共有癌エピトープの作製方法
Kefalides et al. Heterogeneity of antibodies in Goodpasture syndrome reacting with type IV collagen
CN117999350A (zh) 一种t细胞表位序列的鉴定方法及其应用
CN118475596A (zh) 用于针对纤维板层型肝细胞癌(fl-hcc)和其他癌症的免疫治疗的肽和抗原结合蛋白
CN110431236A (zh) 肿瘤组织的免疫分析
CN117441103A (zh) 使用滤泡性t细胞的新型医疗技术
CN113272419A (zh) 制备治疗性t淋巴细胞的方法
WO2024023331A1 (en) Peptides and combinations of peptides for use in immunotherapy against oropharyngeal squamous cell carcinoma (opscc) and other cancers
HK1242779A1 (en) Immunogenic mutant peptide screening platform
CN112300261A (zh) 一种衍生自afp的肿瘤抗原短肽
JP2008521820A (ja) 免疫原性ペプチドを同定および設計するための方法
HK1242779B (zh) 免疫原性突变体肽筛选平台